Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants

Condition:   Poliomyelitis Intervention:   Biological: nOPV2 Sponsors:   Fidec Corporation;   Bill and Melinda Gates Foundation Not yet recruiting

Source: ClinicalTrials.gov - September 5, 2021 Category: Research Source Type: clinical trials